Armata Pharmaceuticals (ARMP) Total Debt (2018 - 2026)
Quarterly results put Total Debt at $88.0 million for Q1 2026, up 217.67% from a year ago — trailing twelve months through Mar 2026 was $88.0 million (up 217.67% YoY), and the annual figure for FY2025 was $103.1 million, up 357.26%.
Armata Pharmaceuticals has reported Total Debt over the past 7 years, most recently at $88.0 million for Q1 2026.
- Total Debt reached $88.0 million in Q1 2026 per ARMP's latest filing, down from $103.1 million in the prior quarter.
- Across five years, Total Debt topped out at $107.0 million in Q1 2024 and bottomed at $22.3 million in Q3 2023.
- Median Total Debt over the past 4 years was $41.4 million (2024), compared with a mean of $52.8 million.
- Peak annual rise in Total Debt hit 357.26% in 2025, while the deepest fall reached 74.12% in 2025.
- Over 4 years, Total Debt stood at $23.7 million in 2023, then decreased by 4.79% to $22.5 million in 2024, then soared by 357.26% to $103.1 million in 2025, then fell by 14.64% to $88.0 million in 2026.
- Business Quant data shows Total Debt for ARMP at $88.0 million in Q1 2026, $103.1 million in Q4 2025, and $63.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.99 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 87.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.98 Mn |
| Dec 31, 2025 | 103.06 Mn |
| Sep 30, 2025 | 63.33 Mn |
| Jun 30, 2025 | 33.45 Mn |
| Mar 31, 2025 | 27.69 Mn |
| Dec 31, 2024 | 22.54 Mn |
| Sep 30, 2024 | 41.36 Mn |
| Jun 30, 2024 | 48.26 Mn |
| Mar 31, 2024 | 107.03 Mn |
| Dec 31, 2023 | 23.67 Mn |
| Sep 30, 2023 | 22.28 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Jun 30, 2020 | 1.62 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 970,000.00 |
| Sep 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 769,000.00 |
| Dec 31, 2018 | 970,000.00 |